S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
NASDAQ:SPPI

Spectrum Pharmaceuticals (SPPI) Stock Forecast, Price & News

$1.07
-0.03 (-2.73%)
(As of 05/31/2023 ET)
Compare
Today's Range
$1.06
$1.12
50-Day Range
$0.65
$1.31
52-Week Range
$0.32
$1.57
Volume
880,343 shs
Average Volume
2.21 million shs
Market Capitalization
$219.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.44

Spectrum Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
127.8% Upside
$2.44 Price Target
Short Interest
Healthy
1.50% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.84mentions of Spectrum Pharmaceuticals in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$63,412 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.15) to $0.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

261st out of 1,006 stocks

Pharmaceutical Preparations Industry

120th out of 492 stocks


SPPI stock logo

About Spectrum Pharmaceuticals (NASDAQ:SPPI) Stock

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Boston, MA.

Receive SPPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectrum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SPPI Stock News Headlines

World-Renowned Brazilian Restaurant Debuts in Canada
Invest in Debut's Exclusive Franchise of Acclaimed Brazilian Churrasco Restaurant Brand.
Highly Profitable Restaurant Brand Expands to Canada
Invest in the Canadian Expansion with Debut: The Exclusive Franchisee with Proven Success.
Q1 2023 Assertio Holdings Inc Earnings Call
Expert Ratings for Spectrum Pharma
See More Headlines
Receive SPPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectrum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SPPI Company Calendar

Last Earnings
3/22/2023
Today
5/31/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:SPPI
CUSIP
84763A10
Employees
163
Year Founded
2002

Price Target and Rating

Average Stock Price Forecast
$2.44
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$0.75
Forecasted Upside/Downside
+127.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-75,400,000.00
Pretax Margin
-263.04%

Debt

Sales & Book Value

Annual Sales
$25.73 million
Book Value
$0.13 per share

Miscellaneous

Free Float
199,720,000
Market Cap
$219.63 million
Optionable
Optionable
Beta
2.23

Social Links


Key Executives

  • Thomas J. RigaThomas J. Riga
    President, Chief Executive Officer & Director
  • Nora E. Brennan
    Chief Financial Officer & Executive Vice President
  • Michael A. Grabow
    Chief Business Officer & Executive Vice President
  • Keith M. McGahanKeith M. McGahan
    Secretary, Chief Legal Officer & Executive VP













SPPI Stock - Frequently Asked Questions

Should I buy or sell Spectrum Pharmaceuticals stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Spectrum Pharmaceuticals in the last year. There are currently 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SPPI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SPPI, but not buy additional shares or sell existing shares.
View SPPI analyst ratings
or view top-rated stocks.

What is Spectrum Pharmaceuticals' stock price forecast for 2023?

5 analysts have issued 12 month target prices for Spectrum Pharmaceuticals' stock. Their SPPI share price forecasts range from $0.75 to $4.00. On average, they expect the company's share price to reach $2.44 in the next twelve months. This suggests a possible upside of 125.7% from the stock's current price.
View analysts price targets for SPPI
or view top-rated stocks among Wall Street analysts.

How have SPPI shares performed in 2023?

Spectrum Pharmaceuticals' stock was trading at $0.3685 at the beginning of the year. Since then, SPPI shares have increased by 193.1% and is now trading at $1.08.
View the best growth stocks for 2023 here
.

Are investors shorting Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 3,080,000 shares, a drop of 49.2% from the April 30th total of 6,060,000 shares. Based on an average daily volume of 2,290,000 shares, the short-interest ratio is presently 1.3 days.
View Spectrum Pharmaceuticals' Short Interest
.

When is Spectrum Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our SPPI earnings forecast
.

How were Spectrum Pharmaceuticals' earnings last quarter?

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) posted its earnings results on Wednesday, March, 22nd. The biotechnology company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.03. The biotechnology company had revenue of $10.11 million for the quarter, compared to the consensus estimate of $9.60 million.

What is Joseph Turgeon's approval rating as Spectrum Pharmaceuticals' CEO?

2 employees have rated Spectrum Pharmaceuticals Chief Executive Officer Joseph Turgeon on Glassdoor.com. Joseph Turgeon has an approval rating of 47% among the company's employees. This puts Joseph Turgeon in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Spectrum Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spectrum Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Verastem (VSTM), Exelixis (EXEL), SCYNEXIS (SCYX), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), OPKO Health (OPK), Bausch Health Companies (BHC), Sorrento Therapeutics (SRNE) and Zynerba Pharmaceuticals (ZYNE).

What is Spectrum Pharmaceuticals' stock symbol?

Spectrum Pharmaceuticals trades on the NASDAQ under the ticker symbol "SPPI."

Who are Spectrum Pharmaceuticals' major shareholders?

Spectrum Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Armistice Capital LLC (8.14%), Acadian Asset Management LLC (1.81%), BlackRock Inc. (1.68%), Geode Capital Management LLC (0.86%), Sargent Investment Group LLC (0.54%) and Renaissance Technologies LLC (0.47%). Insiders that own company stock include Francois Lebel, Jeff L Vacirca, Joseph W Turgeon, Keith M Mcgahan, Kurt A Gustafson, Nora Brennan, Seth H Z Fischer, Thomas J Riga and William Ashton.
View institutional ownership trends
.

How do I buy shares of Spectrum Pharmaceuticals?

Shares of SPPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Spectrum Pharmaceuticals' stock price today?

One share of SPPI stock can currently be purchased for approximately $1.08.

How much money does Spectrum Pharmaceuticals make?

Spectrum Pharmaceuticals (NASDAQ:SPPI) has a market capitalization of $221.68 million and generates $25.73 million in revenue each year. The biotechnology company earns $-75,400,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis.

How many employees does Spectrum Pharmaceuticals have?

The company employs 163 workers across the globe.

How can I contact Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals' mailing address is 11500 SOUTH EASTERN AVENUE SUITE 240, HENDERSON NV, 89052. The official website for the company is www.sppirx.com. The biotechnology company can be reached via phone at (617) 586-3900, via email at ir@sppirx.com, or via fax at 702-260-7405.

This page (NASDAQ:SPPI) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -